2.54
price down icon8.63%   -0.24
pre-market  Vorhandelsmarkt:  2.62   0.08   +3.15%
loading

Bioxcel Therapeutics Inc Aktie (BTAI) Neueste Nachrichten

pulisher
Oct 12, 2025

Published on: 2025-10-12 22:14:31 - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

BioXcel Therapeutics announces pricing of $7M public offering - MSN

Oct 12, 2025
pulisher
Oct 12, 2025

Why BioXcel Therapeutics, Inc. (BTAI) Soared Last Week - MSN

Oct 12, 2025
pulisher
Oct 12, 2025

How BioXcel Therapeutics Inc. (BX20) stock reacts to stronger dollarWeekly Stock Analysis & Low Risk Profit Maximizing Plans - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

BioXcel Therapeutics Receives Positive FDA Feedback - MSN

Oct 10, 2025
pulisher
Oct 10, 2025

Sentiment analysis tools applied to BioXcel Therapeutics Inc.Weekly Investment Report & Precise Swing Trade Entry Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is BioXcel Therapeutics Inc. stock a smart buy before Fed meetingJuly 2025 Movers & High Conviction Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

BioXcel Therapeutics Inc. stock outlook for YEARTrade Signal Summary & Safe Capital Investment Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

BioXcel Therapeutics Inc. stock daily chart insights2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

What drives BioXcel Therapeutics Inc BX20 stock pricePrice Action Analysis & Double Or Triple Wealth - earlytimes.in

Oct 07, 2025
pulisher
Oct 06, 2025

How BioXcel Therapeutics Inc. (BX20) stock responds to bond marketJuly 2025 Outlook & Growth Focused Entry Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Will BioXcel Therapeutics Inc. stock recover faster than peersQuarterly Portfolio Report & Weekly Watchlist for Hot Stocks - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Is BioXcel Therapeutics Inc. stock reversal real or fakeEarnings Recap Summary & Growth Focused Stock Pick Reports - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

BioXcel Therapeutics Inc. stock chart pattern explained2025 Market Sentiment & Community Driven Trade Alerts - newser.com

Oct 03, 2025
pulisher
Sep 30, 2025

BioXcel Investors Advance Suit Over FDA Study Compliance Issues - Bloomberg Law News

Sep 30, 2025
pulisher
Sep 28, 2025

What analysts say about BioXcel Therapeutics Inc stockMean Reversion Trades & Market Monitoring and Alerts - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

BioXcel Therapeutics Inc Stock Analysis and ForecastSell Signals and Alerts & Control Your Emotions With Discipline Tools - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

User - FinancialContent

Sep 27, 2025
pulisher
Sep 22, 2025

BioXcel Therapeutics stock rating reiterated at Buy by H.C. Wainwright - Investing.com Canada

Sep 22, 2025
pulisher
Sep 19, 2025

Volume spikes in BioXcel Therapeutics Inc. stock – what they meanJuly 2025 Trends & Intraday High Probability Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Real time scanner hits for BioXcel Therapeutics Inc. explained2025 Volatility Report & Weekly High Return Opportunities - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Fundamentals Check: Is BioXcel Therapeutics Inc benefiting from interest rate changesWeekly Trade Report & Technical Analysis for Trade Confirmation - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Short Interest Up 166.4% in August - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

ETF Watch: How cyclical is BioXcel Therapeutics Incs revenue streamAnalyst Upgrade & Risk Controlled Stock Pick Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Aug Reactions: How cyclical is BioXcel Therapeutics Incs revenue streamJuly 2025 Trends & Reliable Price Breakout Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

BioXcel Therapeutics regains Nasdaq compliance after MVLS issue By Investing.com - Investing.com South Africa

Sep 18, 2025
pulisher
Sep 18, 2025

BioXcel Therapeutics regains compliance with Nasdaq market value of listed securities requirements - MarketScreener

Sep 18, 2025
pulisher
Sep 18, 2025

BioXcel Therapeutics Regains Compliance With Nasdaq Market Value of Listed Securities Requirements - 富途牛牛

Sep 18, 2025
pulisher
Sep 18, 2025

BioXcel Therapeutics (BTAI) Regains Nasdaq Compliance - GuruFocus

Sep 18, 2025
pulisher
Sep 18, 2025

BioXcel Therapeutics regains Nasdaq compliance after MVLS issue - Investing.com

Sep 18, 2025
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):